CYC Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Cyclopharm Ltd

Watchlist Manager

Watchlist

Price: 0.47 AUD -2.08% Market Closed

Market Cap: AU$59.1m

C	Cyclopharm Ltd ASX:CYC	AU
W	Wellchange Holdings Co Ltd NASDAQ:WCT	HK

Profitability Summary

Cyclopharm Ltd's profitability score is 6/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

57%

Strong 3Y Average Gross Margin

61%

Declining Gross Margin

69% > 57%

Negative Operating Margin

-53%

Negative 3Y Average Operating Margin

-46%

Declining Operating Margin

-21% > -53%

Negative Net Margin

-53%

Negative 3Y Average Net Margin

-42%

Declining Net Margin

-23% > -53%

Negative Free Cash Flow Margin

-57%

Negative 3Y Average Free Cash Flow Margin

-48%

Declining Free Cash Flow Margin

-25% > -57%

Negative ROE

-54%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-45%

Declining ROIC

-30% > -52%

View All

Hide

Collapse

6 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

57%

Strong 3Y Average Gross Margin

61%

Declining Gross Margin

69% > 57%

Negative Operating Margin

-53%

Negative 3Y Average Operating Margin

-46%

Declining Operating Margin

-21% > -53%